This review highlights antibiofouling polymer interfaces with emphasis on the latest developments using poly(ethylene glycol) and the design new polymeric structures.
Poly(ethylene glycol)
PEG has been the most widely used polymer for antifouling applications, such that it has often been termed the "gold standard" of antifouling polymers. 22, 28 In terms of surface applications, Prime and Whitesides first reported the potential for PEG-derivatives, showing that oligo(ethylene glycol) (OEG) self-assembled monolayers (SAMs) were effective proteinrepellent coatings. 33, 34 However, OEG SAMs are prone to surface defects and have limited application to metal surfaces. 35 Given the limitations of these SAMs, alternative means of attaching PEG to surfaces have been explored.
The effectiveness of PEG, and antifouling polymers in general, depends upon the surface grafting technique and , achievable grafting densities, and the polymer architecture . 36, 37 For this reasonThus, a variety of grafting approaches have been developed to improve the effectiveness of PEG and other antifouling coatings. For example, fFirstly, For example, linear PEG can behas beencan be covalently attached to surfaces, for example, using "grafting to" approaches to form linear polymer brushes [38] [39] [40] . [38] [39] [40] Secondly, PEG methacrylates can also behave also beencan be polymerizsed from initiator pre-treated surfaces using a "grafting from" techniquesapproach ( 34, 35 For this reason, a variety of grafting approaches have been developed to improve the effectiveness of PEG and other antifouling coatings. These include polymerization techniques such as se.g. Surface-Iinitiated
Atom Transfer Radical Polymerization (SI-ATRP))., 31, [41] [42] [43] [44] Using this approachtechnique, effective antifouling brushes arecan be formed consisting of linear polymers with PEG side chains.
but also novel Novel and biomemeticSeveral novel approaches grafting strategies developed specifically for antifouling applications have also been developed. For example, a biologically inspired approach using components of muscle adhesive protein (i.e., L-3,4- dihydroxyphenylalanine, L-DOPA) has been effectively used to attach PEG to surfaces via catechol groups (see Figure 2Figure 2 (B) ). [45] [46] [47] [48] [49] [50] [51] In a separate approach, the amino acid lysine has been used as a polymer brush backbone with PEG. 47, 52-54 42, 47-49 PEG side chains are covalently linked through the primary amine on the lysine residues to form poly(lysine)-graft-PEG (PLL-g-PEG) polymers (see Figure 2Figure 2 (A) ). Some lysine residues on the backbone are left in their native, cationic state, and these residues can adsorb to an anionic metal surface such as titanium oxide. The Further, the lysine side chain can also be functionalized with the integrin ligand, Arg-Asp-Gly (RGD), to endow the surface with the ability to specifically bind to host cells. 53 The poly(lysine) strategy can be combined with a catechol strategy on the same polymer to create a multifunctional polymer anchor. Saxer et al. 47 developed such a polymer ( Figure   2Figure 2), showing that the catechol groups led to increased coating resistance to high ionic salt solutions compared to PLL-g-PEG alone. Despite significant research into PEG's applications on surfaces, its mechanism of action are still not fully understood. [9] [10] [11] 55 PEG's antifouling properties likely stem from steric repulsion associated with a loss of entropy when proteins attempt to adsorb to surfaces. 10, 11 Furthermore, it is likely PEG's hydrophilic nature leads to the formation of a hydration layer which inhibits protein encroachment. 9 Several variables which determine PEG's effectiveness include the grafting density (with higher densities being associated with greater protein repellence), chain length, and type of PEG branching architecture. 37, 56 In addition to being useful for coating macroscopic surfaces, PEG has been effectively used in a variety of nanoparticulate systems. [13] [14] [15] [16] [17] [18] [19] Attaching PEG to nanoparticles, known as PEGylation, gained popularity when liposomes were first PEGylated in the early 1990s. [57] [58] [59] PEGylated liposomes encapsulating the anti-cancer drug doxorubicin became the first commercially available polymeric particulate drug delivery system (Doxil) in 1995. 60 In some cases, PEGylated liposomes or other nanoparticles have greatly reduced blood circulation time after the first dose in animal models. This response appears to be IgMmediated 87, 88 and is termed the accelerated blood clearance (ABC) phenomenon (see Figure   3Figure 3 (A)). [89] [90] [91] Interestingly, the effect is not observed for PEGylated liposomes encapsulating anti-cancer drugs; this is potentially because these drugs are cytotoxic to antibody secreting cells. 
Zwitterionic polymers
Zwitterionic polymers have recently emerged as promising alternatives to PEG. 8, 20, 92 Zwitterionic polymers are electrically neutral materials which contain both a positively charged species and a negatively charged species on the same monomer or, in the case of Figure 4Figure 4 for tests using carboxybetaine).
Zwitterionic surface coatings have recently been shown to have promise in clinically relevant implant models. 104, 105 For example, Liu et al. 105 reported that grafting pSBMA on to titanium alloy orthopaedic/dental implants led to increased osteointegration by promoting mineralization of the implant surface. In addition to surface-grafted polymer architectures, several new hydrogels with zwitterionic polymers appear to be particularly promising. 104, 106, 107 95, 98, 99 Zhang et al., 104 for example, developed a pCBMA hydrogel with long-term resistance to the foreign body reaction, the body's immunological response to implanted foreign objects. . In the foreign body reaction, nonspecific protein adsorption is thought to signal the presence of thean implant to the immune system and set off a cascade of events , setting off a cascade of events leading to thewhich leads to thetriggering the formation of a dense collagen layer around the implant to sequester itthe implant from surrounding tissue. This collagen layer can prevent effective mass transport and electrical communication between an implant and the body. Remarkably, the pCBMA hydrogels implanted in mice resisted the foreign body reaction for three months.
Zhang et al. The investigators showed that pCBMA hydrogels resisted the foreign body reaction for three months when implanted in micethese zwitterionic polymers could reduce the formation of dense collagenous material at the implant site. This was presumably because the surface strongly resisted nonspecific protein adsorption. This effect was attributed , an effect attributed to the surface's strong protein repellent propertiesrepellenceThe authors hypothesizedsuggested that by resisting preventing protein adsorption, allowed the pCBMA hydrogels were able toto prevent the chain of events leading to the formation of the collagen layer. , as protein adsorption is thought to be the first step in the immune response which lead to the formation of the dense collagen layer From an applications viewpoint, this wouldBy preventing the foreign body reaction and the formation of a collagen layer, these pCBMA materials could potentially improve mass transport and electrical communication between an implant and the body.
Zwitterionic polymers' chemical structure can allow for several unique functionalities.
Carboxybetaines, for example, contain multiple functional groups amenable to conjugation.
Further, due to the presence of oppositely charged species on each monomer, zwitterionic materials can be used as switchable surfaces, capable of shifting between cationic, zwitterionic, and anionic states based on the environmental pH. 118 Jiang and co-workers in fact found that in rats, pCBMA-coated gold nanoparticles (pCBGNPs) had a longer half-life in the blood stream in rats than PEG-coated gold nanoparticles (PEG-GNPs)particles.
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A biodistribution study showed that after 5 days after the first injection, 30% of the original dose of pCBMA particles wereremained found in the blood stream, while almost all of the PEGylated particlesPEG-GNPs had accumulated in the been removed to the liver and other organs.
Moreover, unlike the PEGylated particlesPEG-GNPs, the pCBMA particles were able to avoid the ABC phenomenon.
As shown in (Figure 3Figure 3Figure 3Figure 3Figure 3Figure 3Figure 3 , for PEGGNPs the rate of clearance PEG particles was greater after the second dose of PEG-GNPs than the first dose. The clearance rate of pCBMA, on the other hand, did not appear to acceleratechange between the first and second dosesafter the first dose between doses. ).
Consistent with thisthe blood residence time data, blood samples taken after injection showed that the pCBMAPEG nanoparticles were associated with lower associated with elevated blood levels of IgM and IgG, two antibodies thought to underlie the ABC phenomenon ,.
These two antibodies associated with opsonization and removal of nanoparticles from the bloodstreamwhich trigger the immune removal of foreign particles, and presumably cause the accelerated clearance of the PEGylated particles..
The pCB-GNP-injected ratsBMA-conditions had similar levels of IgM and IgG as control rats rats who were not injected with without nanoparticles.
Moreover, unlike the PEGylated particles, the pCBMA particles were able to avoid the ABC phenomenon (Figure 3) . ThusMoreover, unlike the PEGylated particles, the pCBMA particles were able to avoid the ABC phenomenon (Figure 3) . Given such data, zwitterionic species appear to be a promising class of antifouling polymers which may be readily modified at their reactive functional groups for particular biomedical applications.
Poly(hydroxyfunctional acrylates)
Poly(hydroxyfunctional acrylates) include polymers such as poly(2-hydroxyethyl methacrylate) (pHEMA), poly(hydroxypropyl methacrylate) (pHPMA), and poly(Nhydroxyethylacrylamide) (pHEAA). Poly(hydroxyfunctional acrylates) are similar to other PEG alternatives in that they are electrically neutral and hydrophilic.
These polymers have a long history as biomaterials. pHEMA hydrogels, for example, have been conventionally used in a range of biomedical applications, including implants, tissue engineering scaffolds, and contact lenses, for over 25 years. 125, 126114, 115 Recent work has explored both polymer brushes 101, 102, [127] [128] [129] [130] [131] and hydrogels 101, 132, 133 containing hydroxyfunctional acrylates for surface antifouling applications. In vitro protein
absorbency tests with pHEMA demonstrate that it has protein repellence comparable to PEG. 127 Moreover, use of the acrylamide backbone (i.e., pHEAA) can produce surfaces with undetectable protein adsorption from undiluted human blood serum. 101 Similarly, pHPMA brushes can produce ultralow fouling properties similar to zwitterionic poly(carboxybetaine acrylamide) 102 (see Figure 4Figure 4 
Poly(vinylpyrrolidone)
Like the poly(hydroxyfunctional acrylates), poly(vinylpyrrolidone) (PVP) has a long history as a biocompatible polymer, being used as a plasma substitute in the 1930s and later as a food additive. PVP is a highly hydrated species, 146, 147 which likely accounts for its proteinrepellence. 148 Although macroscopic surfaces coated in PVP have received relatively less research attention, PVP does hold promise for surface applications. [149] [150] [151] Notably, Serrano et al. 151 recently tested PVP against human serum and found protein adsorption similar to PEG and
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poly(2-ethyl-2-oxazoline), supporting PVP's utility for biomedical and similar antifouling applications.
PVP has been extensively examined in the context of nanoparticulate systems. A major application for PVP is in micellar systems, [152] [153] [154] [155] [156] [157] although PVP has also been used in liposomes, [158] [159] [160] nanostructured capsules, [161] [162] [163] [164] and drug conjugates. 165, 166 PVP appears to have favourable qualities for drug delivery, including resistance to opsonization and phagocytosis. For example, PVP-conjugated tumor necrosis factor-α (TNF-α) showed a longer blood circulation time and twofold increase in antitumor effect compared to PEGylated TNF-α. 167 However, while most studies in mouse models of cancer find a positive effect of PVP conjugation or coating, 165, [168] [169] [170] [171] Being able to freely rotate in space, PEG may be better therefore able to provide this steric hindranceavoid thisable to formforming a dense conformational cloud providing steric hindrance necessary to sterically hinder protein adsorption. That said, (Gaucher et al., 2009 ).
That saidHoweverThatThat said, thetThe ability of PVP to form such a confirmation cloud is a function of its molecular weight. Therefore, op, and optimisation of this parameter may yield more effective PVP coatings.gs.
Formatted: Space After: 12 pt, Line spacing: Double immunological qualities of PVP is justified.
Poly(2-oxazoline)s
Poly(2-oxazoline)s (POxs) such as poly(2-methyl-2-oxazoline) and poly(2-ethyl-2-oxazoline)
have recently become prominent PEG alternatives. [21] [22] [23] [24] [25] POxs have generated considerable interest in part because they are able to maintain their antifouling character for longer periods than PEG, suffering less oxidative damage in biological and oxidative media. 172 POxs have successfully been used as surface coatings, and POxs have similar protein repellence as PEG when the grafting density is optimised. 22 As with PEG, a variety of surface attachment techniques are available, 21 including "grafting-to," 173, 174 "grafting-from," 175 and the use of poly(lysine)-g-POx brushes.
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Page 19 of 41 Polymer Chemistry Figure 5 . The synthesis and in vivo testing of micellar drug carriers constructed from poly(2-oxazoline)s (POxs). Four diblock or ABA-type triblock polymers were first produced entirely from POxs (A). To tune the hydrophilic/hydrophobic nature of the POx monomers, the length of the 2-alkyl side chains was varied. A methyl or ethyl side chain was used to produce a hydrophilic monomer and a butyl side chain was used to produce a hydrophobic monomer. When combined in an aqueous solution with hydrophobic drugs, these polymers selfassembled into micelles (B). Using this strategy, one of the polymers (polymer P2) was used to encapsulate the anticancer drug Paclixitel (PTX) (P2-PTX micelles). These micelles were tested against empty P2 micelles, a saline control, and a commercially available PTX carrier, Cremophor EL/ethanol (CrEL) in a mouse model of lung cancer (C). At all time points, the P2-PTX formulation performs similarly or better than the CrEL control. POxs have been used in place of PEG in several nanoparticulate systems. Notably, POxs appear promising as the hydrophilic component of block copolymer micelles designed to deliver hydrophobic drugs (see Figure 5Figure 5 for an example). [177] [178] [179] [180] [181] [182] [183] POxs have also been coated on the surfaces of liposomes 184, 185 and nanocapsules 186 to successfully impart stealth properties.
POxs appear to have similar in vivo characteristics as PEG in terms of circulation time and uptake by the reticuloendothelial system. 184, 187 Several recent studies have found that POxs have limited cytotoxicity or immunogenicity in vitro. 183, [188] [189] [190] [191] [192] [193] For instance, Pulkkinen et al. 193 have shown in vivo that poly-ε-caprolactone cross-linked with 2, 2-bis(2-oxazoline) is biocompatible, non-toxic, and is slowly enzymatically degraded over a 12 week period when implanted in rat heart, lung, liver, kidney, spleen and brain tissue. These studies help to allay previous uncertainties about POxs' biocompatibility 28 and encourage further exploration of POxs for nanomedicine and controlled drug release applications.
Poly(glycerol)
Poly(glycerol) (PG) is a common, biocompatible polyol widely used in the food and pharmaceutical industries. Its polyether structure is similar to PEG but also contains hydroxyl groups amenable to functionalization. PG has received attention as an antifouling surface coating over the last 10 years. While surfaces with linear PG have been synthesized, [194] [195] [196] the hyperbranched form appears to be more resistant to protein adsorption 196 and is more extensively studied. PG has been affixed to surfaces both as SAMs [194] [195] [196] [197] [198] [199] and as polymer grafts. [200] [201] [202] [203] [204] [205] While PG coatings have strong resistance to model proteins such as fibrinogen and albumin, 201, 202, 204, 205 they have not yet been extensively tested in complex biological media such as human blood plasma.
PG has been used to impart stealth properties to a number of nanoparticulate systems, including inorganic nanoparticles, 206, 207 liposomes, [208] [209] [210] nanogels, 211 and micelles. 212 In vitro 213, 214 and in vivo, mice studies 215, 216 show that PG is biocompatible and immunologically inertevades the immune system. For instance, Kainthan and Brooks report a plasma half-life for hyperbranched glycerol of approximately 57 hours with no notable toxicity. 216 However a significant build-up and retention of hyperbranched glycerol in organs of the reticuloendothelial system (i.e., the liver and spleen) was observed, an effect which increased with molecular weight. This was presumably due to a lack of biodegradable groups in the molecule, a limitation shared with PEG.
Peptides and peptoids
Synthetic peptides and peptoids may serve as effective antifouling polymers and may overcome the biodegradability issues of PEG and other PEG alternatives. Indeed, peptidebased SAMs, 217, 218 peptoid-based SAMs 219 and peptoid-based polymer brushes 36, [220] [221] [222] [223] [224] [225] have recently been found to be highly effective as antifouling macroscopic surface coatings.
Peptoids, or poly(N-substituted glycine) (see Figure 1Figure 1 ), are synthetically produced mimics of natural peptides with the side chain attached to the nitrogen atom, rather than the α-carbon. The shift of the side chain appears to endow peptoids with increased resistance to proteolytic degradation. 226, 227 Statz and co-workers developed peptoid-coated surfaces that were able to resist protein adsorption from repeated washings with fresh serum for up to five months ( Figure 5) . 220 The antifouling character arises from the peptoid's methoxyethyl side chain, whose structure resembles PEG. The impressive long-term resilience of the surface may be attributed to the anchoring group, a peptide designed to mimic mussel adhesive protein. By choosing amino acid sequences with hydrophilic traits similar to PEG (e.g., L-asparagine and L-glutamine) [228] [229] [230] [231] or by creating polyampholitic sequences, 232 peptides may be used for antifouling purposes in nanoparticulate systems. Indeed, poly(amino acids) have been used to confer stealth properties in several drug delivery systems, including liposomes, [228] [229] [230] [231] inorganic nanoparticles, 232, 233 and micelles. 234 Peptides have a distinct appeal as building blocks for nanoparticles. Because of their biodegradability, peptide-based nanoparticles can potentially avoid the bioaccumulation problems associated with PEG. In addition, peptides can be designed such that they are degraded by proteases at target sites, a trait that can be used for drug targeting. 234 Furthermore, peptides may be able to avoid the ABC phenomenon. Liposomes coated with poly(hydroxyethyl-L-asparagine) were shown to have a reduced ABC effect, with a longer circulation time associated with the second dose, compared to PEG-coated liposomes. 230 By combining poly(amino acids) and PEG, advantages of both can be obtained in a single molecule. 235 For example, ring-opening polymerization of amino acid N-carboxyanhydrides has been effectively used to produce peptide star polymers with a PEG corona and a core containing cationic 236, 237 or anionic 238 poly(amino acids). These star peptides have high biocompatibility and can be functionalized to target cancer cells 236 and deliver and release drug cargo in a pH-dependent manner. 238 Peptides and proteins are commonly used as signalling molecules within the body, a feature which can be utilized to create stealth particles. Rodriguez et al. 239 designed peptides based on human CD47 protein, a molecule which signals to the immune system that its carrier is part of the body and should not be removed by phagocytes. Conjugating these "self-peptides"
to nanobeads led to improved stealth-like properties, with approximately four times as many self-peptide presenting nanobeads remaining in circulation than PEGylated controls at 40 minutes post-injection into mice.
Peptoid-based nanoparticles may also have a nonfouling character. The non-ionic, hydrophilic poly(sarcosine) has been used in block copolymers with poly(γ-methyl Lglutamate) 240 and poly(L-lactic acid) 241 to make opsonization-resistant vesicles for bioimaging. 240, 241 However, despite the apparent promise of peptoids for biomedical applications, limited research has specifically examined their biocompatibility 225 and future work will be needed in this area.
Conclusion
Several polymeric materials, including PEG and a range of PEG alternatives, have been developed to combat protein-based fouling. Interestingly, antifouling properties observed on relatively flat, macroscopic surfaces are maintained at the nanoscale and on surfaces with a variety of geometries, including spherical interfaces.
Although the outlook for antifouling polymers is positive, much of the work is at an earlystage of application. For instance, many of the macroscopic surface coatings reviewed (e.g., Page 24 of 41 Polymer Chemistry polyglycerols) have been tested primarily in vitro with a limited number of model proteins, rather than whole blood fluids. Additional research will be required to test these surfaces against complex biological media and in vivo.
Considerable work has examined protein repellent nanoparticles in clinical settings; noteworthy examples include PEG and HPMA, which have in fact entered the commercial pharmaceutical product development pipeline. PEG has been the most successful polymer in this regard, and its application has served as a model for nanoparticulate drug delivery systems. Given its success, PEG has become the standard antifouling polymer. A challenge for nanomedicine is to bring many of the promising PEG alternatives, such as zwitterionic materials and POxs, to the clinic.
There is still significant scope to develop more effective materials based on novel structures.
We believe numerous research opportunities exist to develop new zwitterionic monomers or monomers based on peptoids or unnatural amino acids. In addition to the development of new monomers, scope also exists for developing improved grafting/surface anchoring strategies.
Continued application of existing anchoring strategies (e.g., using biomimetic catechol groups) as well as the development of new approaches will likely continue to be a basis for new antifouling surfaces. Indeed, combining these surface attachment strategies with new or existing monomers will pave the way for the next generation of antifouling polymer architectures.
